Trial Profile
Phase II study of antineoplastons A10 and AS2-1 in patients with meningioma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Brain cancer
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.